Article
Some behavioural and neurochemical aspects of subacute (±)3,4-methylenedioxymethamphetamine administration in rats

https://doi.org/10.1016/0091-3057(95)00206-CGet rights and content

Abstract

(±)3, 4-methylenedioxymethamphetamine (MDMA; “Ecstasy”), an increasingly popular recreational drug, is known to damage brain serotonin (5-hydroxytryptamine [5-HT]) neurons, whilst also having a less pronounced effect on the dopaminergic system. Treatment with MDMA results in an increased locomotor activity, elevated basal serum corticosterone concentrations, decreased exploratory activity, and changes in body temperature. The aim of this study was to examine the dose related effects of subacute administration of MDMA (5, 10, and 20 mg/kg IP twice daily for 4 days) on home cage locomotor activity, “open field” and “step-down passive avoidance” behaviours, changes due to an 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) challenge, and on plasma corticosterone and brain neurotransmitter concentrations. Total locomotor activity counts were significantly increased by both 10 and 20 mg/kg MDMA for the 4 days of drug administration. There were no significant differences seen in the “open field” or “step down passive avoidance” behaviour, in the 8-OH-DPAT induced hypothermia, or in basal serum corticosterone concentrations. MDMA caused a significant depletion of both 5-HT and 5-hydroxyindoleacetic acid (5-HIAA) in the frontal cortex and amygdala and a significant elevation of dopamine and noradrenaline in the hippocampus. Apart from the increase in locomotor activity following subacute administration, the observed behaviour of the MDMA treated rats would not appear to reflect the substantial changes in brain biogenic amine neurotransmitters.

References (32)

  • J.F. Nash et al.

    Selective crosstolerance to 5-HT1A and 5-HT2 receptor-mediated temperature and corticosterone responses

    Pharmacol. Biochem. Behav.

    (1989)
  • R.E. Poland

    Diminished corticotropin and enhanced prolactin responses to 8-hydroxy-2(di-n-propylamino)tetralin in methylenedioxymethamphetamine pretreated rats

    Neuropharmacol.

    (1990)
  • D.M. Stone et al.

    The effects of 3, 4-methylenedioxymethamphetamine (MDMA) and 3, 4-methylenedioxtamphetamine on monoaminergic systems in the rat brain

    Eur. J. Pharmacol.

    (1986)
  • B.K. Yamamoto et al.

    The acute effects of methylenedioxymethamphetamine on dopamine release in the awakebehaving rat

    Eur. J. Pharmacol.

    (1988)
  • C.W. Callaway et al.

    Serotonin 5-HT1-like receptors mediate hyperactivity in rats induced by 3, 4-methylenedioxymethamphetamine

    Neuropsychopharmacol

    (1992)
  • C.W. Callaway et al.

    Amphetamine derivatives produce locomotor hyperactivity by acting as indirect serotonin agonists

    Psychopharmacol.

    (1991)
  • Cited by (65)

    • Increased anxiety and impaired spatial memory in young adult rats following adolescent exposure to methylone

      2016, Pharmacology Biochemistry and Behavior
      Citation Excerpt :

      This conclusion was based on decreased ambulation and increased elimination of fecal boluses and occupation of corners in the open field. The effect on ambulation was the opposite to that typifying adult rats when tested in the drugged state (López-Arnau et al., 2012), as can also occur with other drugs such as MDMA (Kolyaduke and Hughes, 2013; McNamara et al., 1995). However, the effect on fecal boluses was only typical of males and rats treated during early adolescence.

    • Central amygdala nicotinic and 5-HT1A receptors mediate the reversal effect of nicotine and MDMA on morphine-induced amnesia

      2014, Neuroscience
      Citation Excerpt :

      On the other hand, our results also showed that intra-CeA injection of a higher dose of MDMA (2-μg/rat) alone significantly decreased memory retrieval. In contrast, McNamara et al. (1995) proposed that MDMA can elevate locomotor activity without any impact on step-down passive avoidance learning. MDMA-associated cognitive dysfunctions have been well documented in basic and clinical studies (McCann et al., 1999; Camarasa et al., 2008).

    • Behavioral and neurochemical effects of repeated MDMA administration during late adolescence in the rat

      2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry
      Citation Excerpt :

      Acute MDMA induces 5-HT release from the dorsal raphe nucleus (Bradberry et al., 1990), known to be a major source of 5-HT for the forebrain (Azmitia and Segal, 1978; Jacobs and Azmitia, 1992; Koch and Galloway, 1997), although the subsequent effects of various repeated (experimenter-administered) dosing regimens have produced differential alterations of the 5-HT system. A commonly used neurotoxic dosing regimen (4 injections per day for 1–2 days) depletes monoamine neurotransmitter levels in adult rats, specifically 5-HT and its metabolite, 5-hydroxyindoleacetic acid (5-HIAA), as well as 5-HT markers such as 5-HT transporters (SERT) and receptors, with varying degrees of recovery (Gurtman et al., 2002; McNamara et al., 1995; Perrine et al., 2010). These ‘neurotoxic’ effects are observed in a number of 5-HT projection fields although neuroanatomical specificity is seen with greater depletion in cortical and limbic areas and less in thalamic structures (Battaglia et al., 1991).

    • Rapid development of semistarvation-induced hyperactivity in Dark Agouti rats. Excessive wheel running and effect of 3,4-methylenedioxymethamphetamine (MDMA)

      2013, Appetite
      Citation Excerpt :

      For this reason, these rats have been used as a genetic model of high activity in exercise-related studies (Koch et al., 2005) and have also been presented as a high-anxiety model in studies of anxiogenic behaviour (Mechan et al., 2002). Because acute administration of MDMA causes hyperactivity in DA rats (Callaway et al., 1990; Green, Mechan, Elliott, O’Shea, & Colado, 2003; McNamara, Kelly, & Leonard, 1995; Rodsiri et al., 2011; Spanos & Yamamoto, 1989) that can last for 10–28 days (e.g. Balogh et al., 2004; Walker et al., 2007), the present study characterised ABA/SIH in DA rats and ascertain whether the long-term effect of MDMA-induced hyperactivity would facilitate its development. To examine the long-term effects on activity reported in previous literature, drug administration was performed by a single injection of 12.5 mg/kg and the behavioural experiment began 1 week after that administration.

    View all citing articles on Scopus
    View full text